Retrospective case studies of selective IgAD patients Ellenes J. Zoltán MD Childrens’ Hospital Oradea, Romania Prof. Dr. Maródi László Dept. of Infectology.

Slides:



Advertisements
Similar presentations
Primary deficiencies of the complement system Radana Zachová Institute of Immunology Faculty hospital Prague, Motol.
Advertisements

X- linked agammaglobulinemia Versailles, France October 22, 2004 INGID.
Autistic Spectrum Disorders are the result of a Bowel Disorder?
INFLUENZA COMPLICATIONS. Influenza complications Bacterial superinfections – bacterial pneumonia – croup – respiratory disorders Decompensation of chronic.
G aps, challenges and opportunities Theo Verheij University Medical Center Utrecht Lower Respiratory Tract Infections in Primary Care.
Asymptomatic hypogammaglobulininemic patients Do we need immunoglobulins? Jiří Litzman, Marcela Vlková, Maria Šárfyová Dept Clin Immunol Allergol, Masaryk.
Antibiotherapy study in A&E From 5 to 15 october 2009 A&E department FVHospital Dr. David Tran.
SCREENING FOR CELIAC DISEASE IN EGYPTIAN CHILDREN SCREENING FOR CELIAC DISEASE IN EGYPTIAN CHILDREN Prof. Dr: Mona Abu Zekry -Professor of Pediatrics Head.
Debate re diagnostic criteria Please your comments to:
Clinical and Laboratory Manifestation of Selective IgM Deficiency Jiří Litzman Dept Clin. Immunol. Allergol, St Anne University Hospital Masaryk University,
Hallauer 06/20011 Outcome evaluation of an universal hepatitis B immunisation programme Johannes F. Hallauer M.D. Health Systems Research Charité, Humboldt.
Antibiotic Use in URTI Gary Kroukamp ENT Specialist Kingsbury Hospital.
RESPIRATORY TRACT INFECTIONS: ANTIBIOTIC PRESCRIBING
Diagnosis of Primary Immunodeficiency
Adults with selective IgA deficiency - Health-related quality of life (HRQL) -Risk factors for poor HRQL ESID-INGID-IPOPI Meeting 2012 Ann Gardulf.
Primary Immunodeficiency Disorders (PID) Soheila Alyasin M.D. AssOCIAT Professor of Pediatrics Division of Immunology and Allergy.
Bronchitis in children. Acute upper respiratory tract infections Prof. Pavlyshyn H.A., MD, PhD.
IMMUNOLOGY Whitney Neyhart. IMMUNOLOGY The study of how the body resists disease with its immune system.
PEDIATRIC ASTHMA Anna M. Suray, M.D Respiratory Update Weirton Medical Center March 17, 2008.
CVID in pediatric patients and milder forms Dr. Esther de Vries consultant in pediatric immunology and infectious diseases Jeroen Bosch Hospital, ‘s-Hertogenbosch,
A Patient with Recurring Infections Julia Wright, M.D. Clinical Associate Professor of Medicine Section of General Internal Medicine.
Use of International Autoimmune Hepatitis Group Criteria for Pediatric Patients Use of International Autoimmune Hepatitis Group Criteria for Pediatric.
VILNIUS UNIVERSITY HOSPITAL SANTARISKIU KLINIKOS.
Primary antibody deficiencies in Estonia Sirje Velbri Tallinn Childrens’ Hospital, Estonia.
Fatal outcome in two siblings with thymic hypoplasia and severe combined immunodeficiency Vilnius University Children’s Hospital Pediatric Center Vilnius.
Ward Audit: April Top 10 Diseases (comparing to previous month) April 2014March Pneumonia Pneumonia Acute Upper Respiratory.
The Pediatric PID Register of Bihor County Ellenes J. Z¹, Ritli L. ¹, Miculschi G. ¹, Mihalceanu R. ¹, Praja M. ¹, Cladovan C. ¹, Spineanu R.
IMMUNE SYSTEM Dr. Yıldıran different intracellular signaling pathways Dr. Yıldıran2.
Renal involvement in Henoch-Schönlein purpura Anca Lupu 6 th year (Bagdasar Alina, Gabor Estera) – Faculty of Medicine Scientific supervisor: Associate.
Suspected IFNγ receptor deficiency dr. László Vaszil Buda Children’s Hospital Budapest, Hungary.
The Immune System – in Health and Diseases Dr. Ilan Dalal Pediatric Allergy/Immunology/Infectious Unit Department of Pediatrics E. Wolfson Medical Center,
Chapter 18 AIDS and other Immunodeficiences Dr. Capers
MAJOR EVENTS AND EVOLUTION IN CYSTIC FIBROSIS PATIENTS Author: Alexandra Martin Coordinator: Dr. Reka Borka Balas University of Medicine and Pharmacy Târgu-
Suspected hemophagocytosis in EBV infection P. Rozsíval, E. Pařízková, P. Dědek, T. Chyba Department of Pediatrics University Hospital Hradec Králové Charles.
Late onset of Severe Combined ImmunoDeficiency (?) Bernadett Mosdósi, Pécs-Hungary.
The Study Of Frequency Of Primary ImmunoDeficiency Disorders In Iran And Constructing A Database For Registering The Patients.
Follow-up of a patient with CERNUNNOS deficiency Edyta Heropolitańska-Pliszka Immunology Department Children’s Memorial Health Institute Warsaw, Poland.
CS-1 Elidel ® (pimecrolimus) Cream 1% Safety Update Feb, 2005 Thomas Hultsch, MD Senior Medical Director Novartis Pharmaceuticals Corporation Thomas Hultsch,
Change in Referral Diagnoses and Diagnostic Delay in Hypogammaglobulinaemic Patients. Jiri Litzman Dept. Clin. Immunol. Allergol Masaryk University, Brno,
PID patients in Motol Radana Zachová Institute of Immunology University hospital Prague Motol, Czech Republic ESID Prague Spring meeting 2005.
Epidemiology of nasal polyp Dr T Balasubramanian.
Asthma in a Nutshell Holger Link, MD. The Complexity of Asthma Immune System Environment Injury and Repair Genes.
Immune deficiency disorders
Allergology. Basic concepts n Allergy is an inappropriate and harmful response to normally harmless substance n Allergy is usually caused by proteins.
Background Type your answer / solution here Write hypothesis before you begin the experiment This should be your best educated guess based on your research.
Background Type your answer / solution here Write hypothesis before you begin the experiment This should be your best educated guess based on your research.
The Natural History of Benign Thyroid Nodules JAMA. 2015;313(9): doi: /jama Modulator Prof. 전숙 / R1 윤수진.
RHEUMATOLOGY TESTING Maureen Sestito, D.O. PCOM Internal Medicine Residency.
Immune-deficiencies for batch 17-MBBS Yr 1 Dr. P. K. Rajesh. M.D.
Surveillance diagnoses 465.9URI 462Acute Pharyngitis 461.9Acute Sinusitis 466Acute Bronchitis 463Acute Tonsillitis Viral Infection 460Common Cold.
Copyright © 1999 American Medical Association. All rights reserved.
Primary immunodeficiencies in adults (Lithuanian experience)
Nodular lymphoid hyperplasia
Evaluation and treatment of allergic fungal sinusitis. II
Table 1. Laboratory Data on Admission
Acute hepatitis of uncertain cause, rule out EBV related
Acute viral hepatitis type C
Chlamydophila (Chlamydia) pneumoniae serology and asthma in adults: A longitudinal analysis  Rafael Pasternack, MD, PhD, Heini Huhtala, MSc, Jussi Karjalainen,
Compliance with Evidence Based Guidelines
HEPATOCELLULAR CARCINOMA (HCC) at
The prospective study and the new ESPGHAN protocol
Evaluation and treatment of allergic fungal sinusitis. II
Wheezy Infant Prof.Dr.Reha Cengizlier
Primary biliary cirrhosis, AMA negative
INTRIGUING COMBINATION OF MUTATIONS IN WAS PATIENT
CVID- Major features Recurrent pyogenic infections, with onset at any age Increased incidence of autoimmune disease Total immunoglobulin level < 300 mg/dL.
Abstract Decreased Inappropriate Antibiotic Use Following a Korean National Policy to Prohibit Medication Dispensing by Physicians Sylvia Park, PhD; Stephen.
Herpesviruses and the microbiome
Infection outcomes in patients with common variable immunodeficiency disorders: Relationship to immunoglobulin therapy over 22 years  Mary Lucas, BSc,
common rheumatologic diagnoses
Presentation transcript:

Retrospective case studies of selective IgAD patients Ellenes J. Zoltán MD Childrens’ Hospital Oradea, Romania Prof. Dr. Maródi László Dept. of Infectology and Pediatric Immunology, University of Debrecen, Hungary

s IgAD - most frequent PID - co-morbidities: - atopic diseases - autoimmune diseases - malignancies OR asymptomatic, diagnosed by fortune

Goals of the study to detect those factors that can influence +/- the clinical presentation and prognosis of the sIgAD

Methods Analysis of the clinical and laboratory data of the sIgAD patients treated at the Dept. of Infectology and Pediatric Immunology of the Debrecen University, period diagnostic criteria of the sIgAD (ESID): –age > 3 yrs –se IgA < 0.05 g/l at least 2 times, measured in more than 3months –secr IgA not detectable –other PID and secondary ID excluded

Studied parameters Family history: –PID, AID, neo. in relatives of I. and II. degree –atopic diseases in relatives of I. degree Personal history: –atopy, AID, malignancies –infections clinical presentation and lab parameters of the sIgAD during the follow-up period

Results 1.

Results 2. Age : 5,6- 24,9 yrs. (average 12,4) Follow-up period: 2 months- 8 yrs.

Family immunological history PID: sIgAD 1 case mother, 2 cases brothers AID: 1-1 ITP, RA, colitis ulcerosa in one of the parents Neo: –I. degr. relatives.: 1 case –I and II. deg. Rel.: 1 case –II. deg.. Rel.: 9 cases, 2 cases cumulated Atopic diseases I. d.r.: 10 cases Neo and AID: 1 family

Personal immunological history Atopic diseases: –33 cases (64,7%): M 26 (76,4%), F 7 (41,1%) –asthma: 11 patients –rhinitis allergica: 15 pts –asthma and rhinitis: 4 pts –derm. atopica, urticaria, food allergies –10 families: one atopic parent→ 9 atopic children (90%)

Atopic patients

AID JRA 3 pts co-morbidities: –2 pts sIgAD + JRA + Rhinitis allergica –1 pt sIgAD + JRA + Sp AD

Infections Recurrent purulent upper respiratory tract inf: 42 pts frequent infections: sinusitis, pharyngitis, tonsillitis rare inf.: otitis, stomatitis aphtosa frequency of the URTI related with aging: –decreased - 29 pts –increased - 4 pts –same- 9 pts LRTI: 3 bronchitis, 3 pneumonia, not recurrent

Infections 2.

Infections 3. O-R-L interventions: 30 pts –2 tonsillectomia –14 pts adenectomia –16pts tonsilloadenectomia decrease of respiratory infections after the surgical interventions: 3 pts !

Labor 1. IgG: 7 pts g/l, extremely rare infections IgG subclasses (20): 13 NV, 3 IgG2 ↓, 2 IgG4 ø, 1 pt IgG2↓+ IgG4 ø - recurrent infections SpAB (42): 32 NV, 10 ↓ –recurr. Inf.: - a-HIB ø + IgG2↓+ IgG4 ø »a-HIB ø + a- SPn negative test vaccination IgM↑ (IgG- NV): 3 pts: rare inf. IgE ↑: 18 pts- 16 atopic diseases (also in other 17 pts, with normal IgE values!)

Labor 2. Complement (CH50, C3, C4): 24 pts Ly-subpopulations:29 pts NV T-cell activity: 4 pts JRA pts: RF negative, ANA gran. pos. Viral serology: –EBV, CMV 3 pts: IgM neg, IgG pos. –HBs-Ag, anti-HCV Ab: 2 pts, negative

Comments 1. M/F = 2:1 (N = 51) gender as risk factor ? Familial risk factors: –neo. I dr. 1 family (2%) →not RF for IgAD –AID I dr 3 pts (6%) → relevancy ? –IgAD 1 family ; IgAD inheritance TACI-R ? –Atopic parents: not RF for IgAD, but RF for associated atopic disease –cumulated immunological disturbancies: RF for IgAD ?

Families with aggregated immunological disturbancies 1.

Families with aggregated immunological disturbancies 2.

Personal immunological history Atopic diseases: 64,7% of pts, M 76,4 %, F 41,1 % ↑general population → IgAD: RF for atopic diseases JRA 3 pts (11,76%) ↑ general population → IgAD: RF for AID ? IgAD and IgG subclass deficiencies (IgG2 and IgG4): which one is the cause of the recurrent URTI ? AID, atopy associated with IgAD does not increase the frequency of URTI! The frequency of URTI ↓ aging tonsillotomia does not ↓ the frequency of URTI!! ↑ total IgG-protection against URTI?